Electron beam collimators for non-standard field sizes and shapes are typically fabricated using Styrofoam molds to cast the aperture cut-out. These molds are often produced using a dedicated foam cutter, which may be expensive and only serves a single purpose. An increasing number of radiotherapy departments, however, has a 3D printer on-site, to create a wide range of custom-made treatment auxiliaries, such as bolus and dosimetry phantoms. The 3D printer can also be used to produce patient-specific aperture cut-outs, as elaborated in this note. Open-source programming language was used to automatically generate the mold's shape in a generic digital file format readable by 3D printer software. The geometric mold model has the patient's identification number integrated and is to be mounted on a uniquely fitting, reusable positioning device, which can be 3D printed as well. This assembly likewise fits uniquely onto the applicator tray, ensuring correct and error-free alignment of the mold during casting of the aperture. For dosimetric verification, two aperture cut-outs were cast, one using a conventionally cut Styrofoam mold and one using a 3D printed mold. Using these cutouts, the clinical plan was delivered onto a phantom, for which the transversal dose distributions were measured at 2 cm depth using radiochromic film and compared using gamma-index analysis. An agreement score of 99.9% between the measured 2D dose distributions was found in the (10%-80%) dose region, using 1% (local) dose-difference and 1.0 mm distance-to-agreement acceptance criteria. The workflow using 3D printing has been clinically implemented and is in routine use at the author's institute for all patient-specific electron beam aperture cut-outs. It allows for a standardized, cost-effective, and operator-friendly workflow without the need for dedicated equipment. In addition, it offers possibilities to increase safety and quality of the process including patient identification and methods for accurate mold alignment.
| INTRODUCTION
For a long time, electron beam therapy has been an important, costfriendly modality for the irradiation of superficial tumors, with minimal dose to the underlying normal tissues.
1,2 Modulation of the electron fields may improve the dose conformity 3 and has been extensively investigated using the photon multi-leaf collimator (MLC) [4] [5] [6] or a dedicated electron MLC. 7, 8 Nevertheless, the use of static electron fields remains common 9 and collimation is typically performed using aperture cut-outs placed in the electron applicator at a small distance from the patient's skin. 10 Collimators for non-standard field sizes and irregular shapes are typically cast in Cerrobend using patient-specific Styrofoam molds.
These molds are often produced using a dedicated foam cutting machine, which may be expensive and mainly serves a single purpose. In addition, Styrofoam panels are bulky and require dedicated storage space, which represents a cost as well. Additive manufacturing or 3D printing may offer a valuable alternative solution for these conventional, machine cut Styrofoam molds.
An increasing number of radiation oncology centers have a 3D
printer available on-site, for instance to create individualized bolus, 11 dosimetry phantoms 12 and immobilization. 13 3D printing likewise allows to produce the molds for the production of patient-specific aperture cut-outs. As such, a single, relatively inexpensive device with a single raw material type can be used to create a wide range of patient-specific treatment auxiliaries. This proof of concept study describes a 3D printing solution for the production of patient-specific aperture cut-outs, including a dosimetric comparison with conventionally produced apertures.
| MATERIALS AND METHODS

2.A | Clinical plan
The data of a patient with recurring squamous cell carcinoma of the nasal cavity, treated with 33 fractions of 2 Gy, were used retrospec- 
2.C | 3D printer settings
The .STL-file of the mold was converted to GCODE, printable on a fused depositioning modeling 3D printer (type N2 Plus, Raise3D, Costa Mesa, CA, USA), using the ideaMaker slicing engine software (version 3.1.6, Raise3D). The main slicer settings were an infill density of 5%, four shells and a layer height of 0.25 mm. A raft was added by the software to enhance adhesion of the 3D printed mold to the printer bed. The commonly used polylactic acid (PLA) was used as filament material for the 3D printer, using an extrusion temperature of 215°C and a heated bed temperature of 60°C. The melting point T m of PLA amounts to around 150°C, allowing it to withstand the hot Cerrobend (T m ≃ 70°C) during casting of the aperture cut-out.
2.D | Dosimetric validation
Two aperture cut-outs were available for the clinical plan: one using the 3D printed mold and positioning device and one using 
| DISCUSSION
In this technical note, a proof of concept for the production of patient-specific electron beam aperture cut-outs using 3D printing technology has been elaborated. The proposed workflow allows for the production of aperture cut-outs without dedicated foam cutting equipment and without dedicated foam material, both of which may represent a significant cost in terms of monetary or storage resources.
Instead, a single, relatively inexpensive and versatile 3D printer with a single raw material can be used to create a wide range of patient-specific treatment auxiliaries besides the molds for aperture cut-out production, such as individualized bolus, 11 dosimetry phantoms, 12 and immobilization. 13 In addition, the proposed workflow allows for introduction of a number of measures to enhance safety and quality in the aperture production process, including patient identification and accurate, error-free alignment during casting.
A dosimetric verification was included in this study, comparing the dose distributions obtained with an aperture cut-out cast using a 3D printed mold and a conventional Styrofoam mold, respectively. A gamma-index agreement of 99.9% was found in the dose region relevant for this proof of concept study, that is, the penumbra region.
A limitation of this study is that only one such direct dosimetric comparison between both workflows was performed. For the performed measurement, however, the agreement score in the penumbra region was excellent. In addition, the proposed 3D printing workflow produces a mere geometric reproduction of the mold's contour generated with the conventional workflow, for which no dosimetric differences should be expected.
Following this proof of concept study, the 3D printing workflow for the production of patient-specific aperture cut-outs has been A reduction in the 3D printing times may be achieved optimizing the slicing engine settings. More importantly, the proposed workflow may be further enhanced by scripting the creation of the STL-file for the mold in the TPS. This is enabled in the authors' institute's TPS using C# (Microsoft Corporation, Redmond, WA, USA) programming language and is currently being pursued. As such, a streamlined workflow can be envisioned in which the required mold can be exported straight from the TPS, converted to GCODE and sent directly to a 3D printer.
In summary, 3D printing allows for a standardized, operatorfriendly workflow for the production of patient-specific electron beam aperture cut-outs without the need for specific equipment to fabricate molds. The proposed workflow includes possibilities to increase safety and quality of the process including patient identification and methods for accurate mold alignment.
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